By Iain Gilbert
Date: Monday 13 May 2024
LONDON (ShareCast) - (Sharecast News) - Life sciences business Aptamer said on Monday that its current sales pipeline was "strong", with over £3.0m in advanced stage discussions.
Aptamer said a proportion of these advanced-stage deal negotiations were anticipated to progress through its laboratory before the end of the financial year, with the anticipated deal value being in addition to the roughly £1.4m of existing signed deals already at various stages of completion in the production laboratory.
The AIM-listed group noted that revenue recognition on all signed deals was further subject to the receipt of target material in a timely manner from customers and scientific attrition.
Aptamer added that it was continuing to make strides in rebuilding its sales pipeline and "revitalising operations" throughout the laboratory, leading to a growing pipeline conversion, including the successful acquisition of repeat business.
"The company looks forward to providing further updates on conversion of the pipeline to contracts before the year-end. Additionally, there is considerable potential for significant value delivery from ongoing activities in the drug delivery space, with a growing interest from various companies seeking to address the substantial unmet need in this field using Optimer and Optimer+ technologies," said Aptamer.
As of 1415 BST, Aptamer shares were up 2.33% at 0.75p.
Reporting by Iain Gilbert at Sharecast.com
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 0.23p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.45p |
52 Week Low | 0.22p |
Volume | 5,238,955 |
Shares Issued | 1,920.34m |
Market Cap | £4.42m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:41 | 1,000,000 @ 0.24p |
16:01 | 40,000 @ 0.23p |
15:39 | 1,000,000 @ 0.22p |
15:37 | 1,083,188 @ 0.23p |
15:06 | 1,666 @ 0.24p |
You are here: research